The Entrepreneur in Residence Program (EIR) is a 1-3 year opportunity for individuals to join and work on selected CTeD projects. Candidates will be chosen according to matched skills, backgrounds and aspirations. The EIR program allows Fellows in training to use their professional and academic experience to help drive our projects forward while also acquiring new and valuable experiences in biotech development and start-ups. CTeD recruits one EIR per start-up project. We encourage entrepreneurs to contact us to explore opportunities of working together to develop new technologies and create companies that will impact healthcare and the economy, both locally and globally.
Past and Current Entrepreneurs
Brian is the Commercial Founder and Executive Chairman of CognaLearn, which is a successful spinoff from the Duke-NUS InteLearn methodology, started by Brian when he was an EIR with CTeD. He is also an Adjunct Professor at Embry-Riddle Aeronautical University Asia in Singapore and has appeared as an Aviation Analyst on Channel NewsAsia. He holds a BS in Industrial Engineering from Columbia University and an MBA in Finance from Duke University. He is the President of the Duke University Alumni Club of Singapore and a member of the Singapore Institute of Directors.
Mahmood has 15 years of experience in Drug Discovery and Development in large pharmaceutical companies. He is motivated to help deliver commercially viable platforms and therapeutics, which will ultimately address unmet medical needs. As a CTeD EIR, Mahmood has worked closely with Professor David Silver to help formulate the scientific and business plan for a biotech startup, as well as prepared and delivered pitch to potential investors. Travecta Therapeutics Pte Ltd is founded as a startup based on a drug delivery platform resulting from Professor David Silver's research. Mahmood is currently focused on realising the commercial potential of Professor Stuart Cook’s research.
Gayatri was previously Executive Director of Yukti Bioscience Pte Ltd, and prior to this a Programme Manager at Cell Therapy Catapult. She was also an Intellectual Property Manager with Isis Innovation Ltd. She has more than 10 years of technology transfer and commercialization experience including analyses of medical need, market opportunity, regulatory pathway, reimbursement strategy, and exclusivity through intellectual property protection. She received her Ph.D. in Biochemistry from University College London, University of London. She also received a master’s degree in International Health Technology Assessment from Sheffield University.